RecensMedical, Inc. (KOSDAQ:394420)

South Korea flag South Korea · Delayed Price · Currency is KRW
29,650
-750 (-2.47%)
At close: Apr 28, 2026
-21.14%
Market Cap 321.71B
Revenue (ttm) 8.83B
Net Income (ttm) -19.12B
Shares Out 10.85M
EPS (ttm) -2,890.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 406,786
Average Volume 1,874,111
Open 31,000
Previous Close 30,400
Day's Range 28,975 - 31,900
52-Week Range 17,550 - 39,900
Beta n/a
RSI 71.81
Earnings Date Jun 29, 2026

About RecensMedical

RecensMedical, Inc. operates as a medical device company specializing in precision cooling therapy and transdermal drug delivery solutions. The company engages in the development of precision medical cooling device in the fields of ophthalmology and dermatology. The company’s products include OcuCool, a hand-held, cooling anesthesia device that provides rapid and controlled cooling to the conjunctiva and sclera, and TargetCool, a handheld device that delivers rapid, precise, and controlled cooling to the skin tissue for the temporary reduction ... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 394420
Full Company Profile

Financial Performance

In 2025, RecensMedical's revenue was 8.83 billion, an increase of 41.05% compared to the previous year's 6.26 billion. Losses were -19.12 billion, 143.8% more than in 2024.

Financial Statements

News

There is no news available yet.